XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
  Depression
  Neuropsychiatry
  Personality Disorders
  Bulimia
  Anxiety
  Substance Abuse
   Alcohol
   Smoking
   Amphetamine
   Opiates
   Cannabis
   Cocaine
  Suicide
  CFS
  Psychoses
  Child Psychiatry
  Learning-Disabilities
  Psychology
  Forensic Psychiatry
  Mood Disorders
  Sleep Disorders
  Peri-Natal Psychiatry
  Psychotherapy
  Anorexia Nervosa
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

Cannabis Channel
subscribe to Cannabis newsletter

Latest Research : Psychiatry : Substance Abuse : Cannabis

   DISCUSS   |   EMAIL   |   PRINT
Increase in psychotic symptoms predicts relapse to cannabis use
Aug 9, 2006, 12:41, Reviewed by: Dr. Venkat Yelamanchili

This was the first prospective study to explore systematically the relationship between cannabis use and psychotic symptoms and relapse, relative to other risk factors, over a 6-month period using highly sensitive measures and frequent follow-up.

 
There may be a two-way relationship between cannabis use and psychosis, according to a new study from Australia. Published in the August issue of the British Journal of Psychiatry, the study found that more frequent cannabis use was associated with a higher risk of psychotic relapse, and more severe psychotic symptoms were associated with increased risk of cannabis relapse.

This was the first prospective study to explore systematically the relationship between cannabis use and psychotic symptoms and relapse, relative to other risk factors, over a 6-month period using highly sensitive measures and frequent follow-up.

At the start of the study, 84 people with recent-onset psychosis were assessed, and 81 were followed up weekly for 6 months, using telephone and face-to-face interviews.

Over 70% of the participants were male, and the average age was 24. Nearly 80% were single and 76% were on disability/unemployment benefits. The average duration of untreated psychosis was 118 days.

It was found that the risk of psychotic relapse increased by approximately 6.4% with each additional day of cannabis use within a 1-week period.

There was a high rate of cannabis relapse, with 61% of participants increasing their cannabis use to a level that met the definition of a cannabis relapse.

After taking into account medication adherence, life stress, other substance use and age at onset of regular cannabis use, psychotic symptom severity was predictive of a cannabis relapse.

These results are consistent with the reports of participants that cannabis use is one way of coping with an increase in positive psychotic symptoms, such as delusions and hallucinations.

The severity of symptoms of depression and anxiety at the start of the study also emerged as a significant predictor of time to psychotic relapse (but not to a relapse in cannabis use), although this finding needs further investigation.

The authors of the study comment that the use of repeated- measures design to obtain a detailed picture of symptoms, medication, stress and substance use provides the best evidence to date for a strong association between cannabis use and psychotic relapse.

Although further research is needed, this study suggests that when compared with the effect of cannabis use, other risk factors for relapse such as duration of untreated psychosis, adherence to medication and chronic and acute stress have less impact on the relapse process.

The findings of this study highlight the need for early intervention programmes to target both cannabis use and psychotic symptom severity in young people.
 

- August issue of the British Journal of Psychiatry
 

bjp.rcpsych.org

 
Subscribe to Cannabis Newsletter
E-mail Address:

 



Related Cannabis News

Increase in psychotic symptoms predicts relapse to cannabis use
New PET Radiotracer to Visualize Cannabinoid Receptors Developed
Cannabis Based Medicine to be Supplied in Spain
Call for public health campaign on cannabis
Canada approved Cannabis extract Based Drug


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us